BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 13129413)

  • 1. Cost-effectiveness league tables: valuable guidance for decision makers?
    Mauskopf J; Rutten F; Schonfeld W
    Pharmacoeconomics; 2003; 21(14):991-1000. PubMed ID: 13129413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness league tables: more harm than good?
    Drummond M; Torrance G; Mason J
    Soc Sci Med; 1993 Jul; 37(1):33-40. PubMed ID: 8332922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stochastic league tables: an application to diabetes interventions in the Netherlands.
    Hutubessy RC; Niessen LW; Dijkstra RF; Casparie TF; Rutten FF
    Health Econ; 2005 May; 14(5):445-55. PubMed ID: 15386648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can cost-effectiveness results be combined into a coherent league table? Case study from one high-income country.
    Wilson N; Davies A; Brewer N; Nghiem N; Cobiac L; Blakely T
    Popul Health Metr; 2019 Aug; 17(1):10. PubMed ID: 31382954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive league table of cost-utility ratios: A systematic review of cost-effectiveness evidence for health policy decisions in India.
    Shah K; Singh M; Kotwani P; Tyagi K; Pandya A; Saha S; Saxena D; Rajshekar K
    Front Public Health; 2022; 10():831254. PubMed ID: 36311623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some guidelines on the use of cost effectiveness league tables.
    Mason J; Drummond M; Torrance G
    BMJ; 1993 Feb; 306(6877):570-2. PubMed ID: 8461776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using cost-effectiveness league tables to compare interventions to prevent sexual transmission of HIV.
    Pinkerton SD; Johnson-Masotti AP; Holtgrave DR; Farnham PG
    AIDS; 2001 May; 15(7):917-28. PubMed ID: 11399964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-per-QALY league tables: their role in pharmacoeconomic analysis.
    Mason JM
    Pharmacoeconomics; 1994 Jun; 5(6):472-81. PubMed ID: 10147264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing health gains, costs and cost-effectiveness of 100s of interventions in Australia and New Zealand: an online interactive league table.
    Carvalho N; Sousa TV; Mizdrak A; Jones A; Wilson N; Blakely T
    Popul Health Metr; 2022 Jul; 20(1):17. PubMed ID: 35897104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness ratios: in a league of their own.
    Birch S; Gafni A
    Health Policy; 1994 May; 28(2):133-41. PubMed ID: 10136058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stochastic league tables: communicating cost-effectiveness results to decision-makers.
    Hutubessy RC; Baltussen RM; Evans DB; Barendregt JJ; Murray CJ
    Health Econ; 2001 Jul; 10(5):473-7. PubMed ID: 11466807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness league tables: think of the fans.
    Drummond M; Mason J; Torrance G
    Health Policy; 1995 Mar; 31(3):231-8. PubMed ID: 10142619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine.
    Siegel JE; Torrance GW; Russell LB; Luce BR; Weinstein MC; Gold MR
    Pharmacoeconomics; 1997 Feb; 11(2):159-68. PubMed ID: 10172935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cost-consequence analysis in healthcare decision-making.
    Mauskopf JA; Paul JE; Grant DM; Stergachis A
    Pharmacoeconomics; 1998 Mar; 13(3):277-88. PubMed ID: 10178653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables.
    Baltussen RM; Hutubessy RC; Evans DB; Murray CJ
    Int J Technol Assess Health Care; 2002; 18(1):112-9. PubMed ID: 11987434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized comparison between league tables and funnel plots to inform health care decision-making.
    Anell A; Hagberg O; Liedberg F; Ryden S
    Int J Qual Health Care; 2016 Dec; 28(6):816-823. PubMed ID: 28423165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda.
    Gafni A; Birch S
    Soc Sci Med; 2006 May; 62(9):2091-100. PubMed ID: 16325975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methods of comparative economic evaluations of therapies and for rational allocation of resources across sectors of health care systems - introduction, advantages, risks].
    Wasem J; Hessel F; Kerim-Sade C
    Psychiatr Prax; 2001 Jul; 28 Suppl 1():S12-20. PubMed ID: 11533902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of league tables and control charts as aids to health service decision-making.
    Marshall T; Mohammed MA; Rouse A
    Int J Qual Health Care; 2004 Aug; 16(4):309-15. PubMed ID: 15252005
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.